Showing 7,141 - 7,160 results of 18,470 for search 'significantly ((((((lower decrease) OR (linear decrease))) OR (a decrease))) OR (teer decrease))', query time: 0.72s Refine Results
  1. 7141

    Identification of narciclasine as a novel NRF2 inhibitor by Hoang Hai Ngo (20564072)

    Published 2025
    “…Finally, we observed that administration of narciclasine significantly decreased the growth of A549 xenografts. …”
  2. 7142

    Data used to generate Fig 1. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  3. 7143

    Data used to generate Table 6. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  4. 7144

    Data used to generate Table 2. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  5. 7145

    Data used to generate Fig 3. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  6. 7146

    Data used to generate Fig 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  7. 7147

    Data used to generate Fig 2. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  8. 7148

    Data used to generate Fig 6. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  9. 7149

    Data used to generate Fig 4. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  10. 7150

    Data used to generate Table 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  11. 7151

    Data used to generate Table 3. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…For <i>Wolbachia</i> trans-infected ones, a irradiation dose as low as 1 Gy could increase the development of the forth-instar larvae while an irradiation dose of 7 Gy induced significantly high mortality to the pupae (<i>p</i> < 0.05). …”
  12. 7152

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  13. 7153

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  14. 7154

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  15. 7155

    Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  16. 7156

    Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  17. 7157

    Data Sheet 1_Impact of a structured food sequence and mobile health monitoring on gestational diabetes outcomes: a clinical trial.pdf by Ria Murugesan (21795620)

    Published 2025
    “…Data analysis included paired and independent t-tests or non-parametric equivalents, with chi-square tests for categorical variables. A p-value <0.05 was considered statistically significant.…”
  18. 7158

    Supplementary file 1_Effects of a personalized PERMA-based intervention on the mental health of junior high school students: a randomized clinical trial.docx by Lei Zhang (38117)

    Published 2025
    “…No significant changes were observed in coping styles, though slight improvements in positive coping tendency (from −0.02 to −0.13) and a slight decrease in negative coping tendency (from −0.02 to −0.01).…”
  19. 7159
  20. 7160

    Raw data. by Camilla Albano (16446679)

    Published 2025
    “…Additionally, we show that a source of lipid-rich external factors provided by fetal bovine serum significantly increases HSV-1 infectivity. …”